MwanzoMEHCQ • OTCMKTS
add
23andMe Holding Co
Bei iliyotangulia
$Â 4.24
Bei za siku
$Â 4.05 - $Â 4.39
Bei za mwaka
$Â 0.47 - $Â 10.81
Thamani ya kampuni katika soko
117.60M USD
Wastani wa hisa zilizouzwa
elfu 575.71
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
OTCMKTS
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 45.15M | -29.49% |
Matumizi ya uendeshaji wa biashara | 65.51M | -34.62% |
Mapato halisi | -99.35M | 52.43% |
Kiwango cha faida halisi | -220.04 | 32.54% |
Mapato kwa kila hisa | — | — |
EBITDA | -45.06M | 35.08% |
Asilimia ya kodi ya mapato | 0.00% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 38.25M | -82.33% |
Jumla ya mali | 159.89M | -59.54% |
Jumla ya dhima | 186.64M | -9.68% |
Jumla ya hisa | -26.74M | — |
hisa zilizosalia | 27.54M | — |
Uwiano wa bei na thamani | -4.37 | — |
Faida inayotokana na mali | -54.88% | — |
Faida inayotokana mtaji | -230.70% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -99.35M | 52.43% |
Pesa kutokana na shughuli | -40.73M | -57.97% |
Pesa kutokana na uwekezaji | elfu -734.00 | 65.80% |
Pesa kutokana na ufadhili | elfu -529.00 | -126.45% |
Mabadiliko halisi ya pesa taslimu | -41.99M | -61.95% |
Mtiririko huru wa pesa | -82.91M | -285.64% |
Kuhusu
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Ilianzishwa
Apr 2006
Makao Makuu
Tovuti
Wafanyakazi
261
